113
Views
11
CrossRef citations to date
0
Altmetric
Original Research

COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan

, , , , , , , & show all
Pages 2629-2641 | Published online: 28 Aug 2018

References

  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of COPD Available from: https://goldcopd.org. Published 2017Accessed December 12, 2017
  • LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
  • WHO [webpage on the Internet]The Top 10 Causes of Death. Fact Sheet No 3102017 Available from: http://www.who.int/mediacentre/factsheets/fs310/en/Accessed March 5, 2018
  • VosTFlaxmanADNaghaviMYears lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592163219623245607
  • HalbertRJNatoliJLGanoABadamgaravEBuistASManninoDMGlobal burden of COPD: systematic review and meta-analysisEur Respir J200628352353216611654
  • FukuchiYNishimuraMIchinoseMCOPD in Japan: the Nippon COPD Epidemiology studyRespirology20049445846515612956
  • MinakataYIchinoseMEpidemiology of COPD in JapanNihon Rinsho201169101721172622073563
  • TakemuraHHidaWSasakiTSugawaraTSenTPrevalence of chronic obstructive pulmonary disease in Japanese people on medical check-upTohoku J Exp Med20052071415016082154
  • ZhongNMoonHSLeeKHTIOtropium Safety and Performance In Respimat(R) (TIOSPIRTM): analysis of Asian cohort of COPD patientsRespirology20162181397140327490162
  • ChubachiSSatoMKameyamaNIdentification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohortRespir Med201611727227927492541
  • HaraguchiMNakamuraHSasakiMDeterminants of chronic obstructive pulmonary disease severity in the late-elderly differ from those in younger patientsBMC Res Notes20169726728686
  • MakitaHNasuharaYNagaiKCharacterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary diseaseThorax2007621193293717573447
  • MiyazakiMNakamuraHChubachiSAnalysis of comorbid factors that increase the COPD assessment test scoresRespir Res2014151324502760
  • NishimuraMMakitaHNagaiKAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121851445222016444
  • SuzukiMMakitaHItoYMClinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort studyEur Respir J20144351289129724232696
  • NishimuraMSimilarities and differences between East and West in COPDRespirology20162181340134127677257
  • LandboCPrescottELangePVestboJAlmdalTPPrognostic value of nutritional status in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199916061856186110588597
  • ScholsAMSlangenJVolovicsLWoutersEFWeight loss is a reversible factor in the prognosis of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981576 pt 1179117979620907
  • BuistASMcBurnieMAVollmerWMInternational variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyLancet2007370958974175017765523
  • de MarcoRAccordiniSCerveriIAn international survey of chronic obstructive pulmonary disease in young adults according to GOLD stagesThorax200459212012514760151
  • KatsuraHEconomic burden of COPD in JapanJpn Med Assoc J2011542110112
  • PolatliMBen KhederAWaliSChronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE studyRespir Med2012106suppl 2S75S8523290706
  • ChakerLFallaAvan der LeeSJThe global impact of noncommunicable diseases on macro-economic productivity: a systematic reviewEur J Epidemiol201530535739525837965
  • FletcherMJUptonJTaylor-FishwickJCOPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age populationBMC Public Health20111161221806798
  • FooJLandisSHMaskellJContinuing to confront COPD international patient survey: economic impact of COPD in 12 countriesPLoS One2016114e015261827092775
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of COPD2014 Available from: https://goldcopd.orgAccessed December 12, 2017
  • IkedaTShiraiwaKIgarashiADeveloping a Japanese version of the EQ-5D-5L value setJ Natl Inst Publ Health20156414755 Japanese
  • EQ-5D-5L User GuideBasic Information on How to Use the EQ-5D-5L Instrument. Version 2.1.2015 Available from: https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-5L_UserGuide_2015.pdfAccessed May 7, 2018
  • ReillyMCZbrozekASDukesEMThe validity and reproducibility of a work productivity and activity impairment instrumentPharmacoeconomics19934535336510146874
  • REILLY ASSOCIATES [webpage on the Internet]WORK Productivity and Activity Impairment Questionnaire: General Health V2.0 (WPAI-GH) [updated October 20, 2004]. Available from: http://www.reillyassociates.net/WPAI_GH.htmlAccessed May 7, 2018
  • IchinoseMTaniguchiHTakizawaAThe efficacy and safety of combined tiotropium and olodaterol via the Respimat((R)) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado((R)) studiesInt J Chron Obstruct Pulmon Dis2016112017202727621608
  • FukahoriSMatsuseHTakamuraNPrevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVCInt J Clin Pract200963226927419196365
  • MatsumotoKSekiNFukuyamaSPrevalence of asthma with airflow limitation, COPD, and COPD with variable airflow limitation in older subjects in a general Japanese population: the Hisayama StudyRespir Investig20155312229
  • WoodruffPGvan den BergeMBoucherRCAmerican Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop ReportAm J Respir Crit Care Med2017196337538128636425
  • LandisSHMuellerovaHManninoDMContinuing to confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013Int J Chron Obstruct Pulmon Dis2014959761124944511
  • HoritaNYomotaMSasakiMEvaluation of the chronic obstructive pulmonary disease assessment test in Japanese outpatientsClin Respir J20148221321924131466
  • PickardASWilkeCJungEPatelSStavemKLeeTAUse of a preference-based measure of health (EQ-5D) in COPD and asthmaRespir Med2008102451953618180151
  • PatelJGNagarSPDalalAAIndirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United StatesInt J Chron Obstruct Pulmon Dis2014928930024672234
  • SouliotisKKousoulakouHHillasGTzanakisNToumbisMVassilakopoulosTThe direct and indirect costs of managing chronic obstructive pulmonary disease in GreeceInt J Chron Obstruct Pulmon Dis2017121395140028546747
  • NishimuraSZaherCCost impact of COPD in Japan: opportunities and challenges?Respirology20049446647315612957